The role and uses of antibodies in COVID-19 infections: A living review
DO Scourfield, SG Reed, M Quastel… - Oxford Open …, 2021 - academic.oup.com
Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global
scientific community striving for solutions to the current pandemic. Characterizing humoral …
scientific community striving for solutions to the current pandemic. Characterizing humoral …
Neutralizing Antibodies in the Prevention and Treatment of COVID-19
RR Razonable, P Chen - Frontiers in immunology, 2022 - frontiersin.org
The COVID-19 therapeutic landscape rapidly evolved throughout the course of the SARS-
CoV-2 pandemic. However, the ingenuity of our community quickly coalesced to identify …
CoV-2 pandemic. However, the ingenuity of our community quickly coalesced to identify …
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
Y Huang, H Sun, H Yu, S Li, Q Zheng… - Antibody …, 2020 - academic.oup.com
The rapid emergence of Coronavirus disease-2019 (COVID-19) caused by severe acute
respiratory syndrome 2 coronavirus (SARS-CoV-2) as a pandemic that presents an urgent …
respiratory syndrome 2 coronavirus (SARS-CoV-2) as a pandemic that presents an urgent …
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
NA Valdez-Cruz, E García-Hernández, C Espitia… - Microbial cell …, 2021 - Springer
SARS-CoV-2 is a novel β-coronavirus that caused the COVID-19 pandemic disease, which
spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far …
spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far …
Neutralizing and enhancing antibodies against SARS-CoV-2
Y Liu, H Arase - Inflammation and Regeneration, 2022 - Springer
The high transmissibility and rapid global spread of SARS-CoV-2 since 2019 has led to a
huge burden on healthcare worldwide. Anti-SARS-CoV-2 neutralizing antibodies play an …
huge burden on healthcare worldwide. Anti-SARS-CoV-2 neutralizing antibodies play an …
Antibodies, epicenter of SARS-CoV-2 immunology
Antibodies against SARS-CoV-2 are the epicenter of the efforts to understand and fight the
COVID-19 pandemic. They play a central role in clearing the virus from infected patients …
COVID-19 pandemic. They play a central role in clearing the virus from infected patients …
A review of the currently available antibody therapy for the treatment of coronavirus disease 2019 (COVID-19)
K Widyasari, J Kim - Antibodies, 2023 - mdpi.com
Monoclonal antibodies are a promising treatment for COVID-19. However, the emergence of
SARS-CoV-2 variants raised concerns about these therapies' efficacy and long-term …
SARS-CoV-2 variants raised concerns about these therapies' efficacy and long-term …
Antibody therapies for the treatment of COVID-19
The outbreak of COVID-19, the disease caused by infection of the coronavirus SARS-CoV-2
that began in December 2019 in Wuhan, China, has caused more than 2 990 559 confirmed …
that began in December 2019 in Wuhan, China, has caused more than 2 990 559 confirmed …
[HTML][HTML] Neutralizing monoclonal antibodies for treatment of COVID-19
PC Taylor, AC Adams, MM Hufford… - Nature Reviews …, 2021 - nature.com
Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …
The SARS-CoV-2 antibodies, their diagnostic utility, and their potential for vaccine development
Antibodies (Abs) are important immune mediators and powerful diagnostic markers in a
wide range of infectious diseases. Understanding the humoral immunity or the development …
wide range of infectious diseases. Understanding the humoral immunity or the development …